Tildrakizumab Now Under FDA Review for Psoriatic Arthritis

by | Mar 16, 2026 | Health

Spread the love
Full results from the pivotal trials submitted to support approval have not yet been reported.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments